Table 3

Immunologic response to antiretroviral therapy among HIV-1-infected children
Increase in CD4% from baseline following initiation of ART in all children (n = 65)
Duration of follow-up (months) Number of childrena Median CD4% (IQR) Median CD4% increase from baseline (IQR) Pb
6 42 23.3% (18.0 – 28.5) 11% (4 – 15) < 0.001
12 37 27% (20 – 34) 15% (7 – 20) < 0.001
18 30 27.5% (16 – 36) 17% (6 – 22) < 0.001
24 25 29% (21 – 38) 18.5% (5 – 22) 0.0001
30 19 32% (19 – 38) 15% (9 – 24) 0.0001
36 12 30.3% (22.5 – 39.5) 18.5% (10.8 – 24.5) 0.002

a Number of children tested at corresponding length of follow-up. Attrition in numbers is attributable to lack of data, loss to follow-up or death.

b Wilcoxon signed ranks test.

Okomo et al.

Okomo et al. BMC Pediatrics 2012 12:95   doi:10.1186/1471-2431-12-95

Open Data